Replies to post #115028 on Biotech Values

[dumaflotchie]

These results are spectacular overall in my view.

I would tend to agree.....in this early report. I am not aware of any other therapy that provided this degree of response to bone mets. The important question of course is how long this lasts because in the first report of smaller caseload, it seemed clear that when one stopped the drug, pain returned almost immediately.

Are you aware of any other therapy that matched this response even in the early reports?

The PSA remains one of those oddities......will be interested in how they explain this.

Most importantly, I guess we need to wait to see if this translates into improved survival.